| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441636 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
This study supports the additional prognostic value of HRQoL data at diagnosis to identify vulnerable subpopulations in elderly NSCLC patients. HRQoL could thus be valuable in selecting patients who will benefit from doublet chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Frédéric Fiteni, Dewi Vernerey, Franck Bonnetain, Fabien Vaylet, Hélène Sennélart, Jean Trédaniel, Denis Moro-Sibilot, Dominique Herman, Hélène Laizé, Philippe Masson, Marc Derollez, Christelle Clément-Duchêne, Bernard Milleron, Franck Morin,